These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24593153)

  • 1. Conditional silencing of topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell survival.
    Ahmed W; Menon S; Godbole AA; Karthik PV; Nagaraja V
    FEMS Microbiol Lett; 2014 Apr; 353(2):116-23. PubMed ID: 24593153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in DNA topoisomerase I level affects growth, phenotype and nucleoid architecture of Mycobacterium smegmatis.
    Ahmed W; Menon S; Karthik PV; Nagaraja V
    Microbiology (Reading); 2015 Feb; 161(Pt 2):341-353. PubMed ID: 25516959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target.
    Ravishankar S; Ambady A; Awasthy D; Mudugal NV; Menasinakai S; Jatheendranath S; Guptha S; Sharma S; Balakrishnan G; Nandishaiah R; Ramachandran V; Eyermann CJ; Reck F; Rudrapatna S; Sambandamurthy VK; Sharma UK
    Tuberculosis (Edinb); 2015 Sep; 95(5):589-98. PubMed ID: 26073894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors.
    Godbole AA; Ahmed W; Bhat RS; Bradley EK; Ekins S; Nagaraja V
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1549-57. PubMed ID: 25534741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing essentiality of transketolase in Mycobacterium tuberculosis using an inducible protein degradation system.
    Kolly GS; Sala C; Vocat A; Cole ST
    FEMS Microbiol Lett; 2014 Sep; 358(1):30-5. PubMed ID: 25047872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
    Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
    Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of topoisomerase I expression by supercoiling sensitive transcription.
    Ahmed W; Menon S; Karthik PV; Nagaraja V
    Nucleic Acids Res; 2016 Feb; 44(4):1541-52. PubMed ID: 26496944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison.
    Godbole AA; Ahmed W; Bhat RS; Bradley EK; Ekins S; Nagaraja V
    Biochem Biophys Res Commun; 2014 Apr; 446(4):916-20. PubMed ID: 24642256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East.
    Ahmad S; Mokaddas E
    Int J Antimicrob Agents; 2004 May; 23(5):473-9. PubMed ID: 15120726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants.
    Kolly GS; Boldrin F; Sala C; Dhar N; Hartkoorn RC; Ventura M; Serafini A; McKinney JD; Manganelli R; Cole ST
    Mol Microbiol; 2014 Apr; 92(1):194-211. PubMed ID: 24517327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
    Jadaun GP; Das R; Upadhyay P; Chauhan DS; Sharma VD; Katoch VM
    Int J Antimicrob Agents; 2009 May; 33(5):483-6. PubMed ID: 19112008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.
    Sandhaus S; Annamalai T; Welmaker G; Houghten RA; Paz C; Garcia PK; Andres A; Narula G; Rodrigues Felix C; Geden S; Netherton M; Gupta R; Rohde KH; Giulianotti MA; Tse-Dinh YC
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4028-36. PubMed ID: 27114277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of Mycobacterium tuberculosis dihydroneopterin aldolase as a molecular target for anti-tuberculosis drug development.
    Falcão VC; Villela AD; Rodrigues-Junior VS; Pissinate K; Eichler P; Pinto AF; Basso LA; Santos DS; Bizarro CV
    Biochem Biophys Res Commun; 2017 Apr; 485(4):814-819. PubMed ID: 28257847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
    Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
    Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of DNA topoisomerase I from Mycobacterium tuberculosis: DNA cleavage and religation properties and inhibition of its activity.
    Godbole AA; Leelaram MN; Bhat AG; Jain P; Nagaraja V
    Arch Biochem Biophys; 2012 Dec; 528(2):197-203. PubMed ID: 23085346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of mce4A gene of Mycobacterium tuberculosis H37Rv using antisense approach.
    Chandolia A; Rathor N; Sharma M; Saini NK; Sinha R; Malhotra P; Brahmachari V; Bose M
    Microbiol Res; 2014; 169(9-10):780-7. PubMed ID: 24556072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type IA topoisomerase inhibition by clamp closure.
    Leelaram MN; Bhat AG; Godbole AA; Bhat RS; Manjunath R; Nagaraja V
    FASEB J; 2013 Aug; 27(8):3030-8. PubMed ID: 23612788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
    Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
    Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.